The FDA submission is backed by robust data from the VALID-ECG pivotal study, which enrolled 198 patients across five clinical sites. The Company believes the study's findings support the clinical ...

The Company believes the study's findings support the clinical equivalence of HeartBeam's synthesized 12-lead ECG where the leads are similar to standard 12-lead ECGs for rhythm and arrhythmia ...

Kardia 12L performed comparably to the standard 12-lead ECG in detecting major morphology-related abnormalities. "AliveCor's Kardia 12L ECG System was born from our vision to leverage AI and ...

The purpose of this study was to evaluate whether the 12-lead ECG could be substituted by ECG sets with a limited number of leads. Materials and methods: The performance of three ECG systems (ie ...

The data was also presented at the 2024 CINC Conference in October. Kardia 12L performed comparably to the standard 12-lead ECG in detecting major morphology-related abnormalities. “AliveCor’s Kardia ...

A perfect week and Iowa State puts itself way out in front of the Big 12 pack. Maybe with an insurmountable lead. How, you might ask, is that possible before we even celebrate MLK Day?

HeartBeam has submitted a 510(k) application to the US Food and Drug Administration (FDA) for its 12-lead electrocardiogram ...

SANTA CLARA, Calif. - HeartBeam, Inc. (NASDAQ: BEAT), a $56.5 million market cap pioneer in medical technology currently trading at $2.12 per share, has announced the submission of a 510(k) ...

An artificial intelligence (AI) model designed to predict a person's biological age (age of body cells and tissues) based on electrocardiogram (ECG) data found a strong association between ECG-age and ...

Electrocardiogram tests may someday be used with an artificial intelligence (AI) model to detect premature aging and ...

However, one important question remains: can ECG data predict future cognitive decline? Answering this could lead to valuable treatments since some ECG issues can be fixed," said Fernando D.